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To test for the role of the P2Y2 receptor (P2Y2-R) in the
regulation of nucleotide-promoted Ca21 signaling in the
lung, we generated P2Y2-R-deficient (P2Y2-R(2/2)) mice
and measured intracellular Ca21i responses (DCa
21
i) to
nucleotides in cultured lung fibroblasts and nasal and
tracheal epithelial cells from wild type and P2Y2-R(2/2)
mice. In the wild type fibroblasts, the rank order of
potencies for nucleotide-induced DCa21i was as follows:
UTP > ATP >> ADP > UDP. The responses induced by
these agonists were completely absent in the P2Y2-
R(2/2) fibroblasts. Inositol phosphate responses paral-
leled those of DCa21i in both groups. ATP and UTP also
induced Ca21i responses in wild type airway epithelial
cells. In the P2Y2-R(2/2) airway epithelial cells, UTP
was ineffective. A small fraction (25%) of the ATP re-
sponse persisted. Adenosine and a,b-methylene ATP
were ineffective, and ATP responses were not affected
by adenosine deaminase or by removal of extracellular
Ca21, indicating that neither P1 nor P2X receptors me-
diated this residual ATP response. In contrast, 2-meth-
ylthio-ADP promoted a substantial Ca21i response in
P2Y2-R(2/2) cells, which was inhibited by the P2Y1 re-
ceptor antagonist adenosine 3*-5*-diphosphate. These
studies demonstrate that P2Y2-R is the dominant puri-
noceptor in airway epithelial cells, which also express a
P2Y1 receptor, and that the P2Y2-R is the sole purinergic
receptor subtype mediating nucleotide-induced inositol
lipid hydrolysis and Ca21 mobilization in mouse lung
fibroblasts.
Extracellular ATP induces a wide variety of responses in
many cell types, including muscle contraction and relaxation,
vasodilation, neurotransmission, platelet aggregation, ion
transport regulation, and cell growth (1–3). The cell surface
receptors mediating these diverse effects of ATP were origi-
nally termed P2 purinoceptors to distinguish them from the
adenosine-activated P1 purinoceptors (4). Subsequently, py-
rimidine nucleotides were also shown to regulate a broad range
of cell functions, leading to speculation about the existence of
separate pyrimidoceptors (5, 6). It is likely, however, that a
common receptor for uridine and adenine nucleotides is present
in many cell types, including neutrophils, pituitary cells, skin
fibroblasts, smooth muscle cells, and specific endothelial and
epithelial cell types (2). This receptor was originally named the
P2U purinoceptor but has been subsequently reclassified as the
P2Y2 receptor (P2Y2-R).
1 The cloning of the murine P2Y2-R
gene (7) and its human counterpart (8) made possible the
definitive identification of this signaling protein as a G-protein
and phospholipase C-coupled receptor that is equipotently ac-
tivated by ATP and UTP but not by diphosphate nucleotides
(9–11).
The lack of specific agonists or antagonists for the growing
number of nucleotide receptor subtypes (e.g. seven P2X and five
P2Y receptors have been identified to date (12, 13)) constitutes
a major obstacle in identifying the specific nucleotide receptor
mediating a given cellular function. One example of the diffi-
culty in assigning receptor subtypes to cellular responses is
illustrated in studies of fibroblasts. Following original studies
by Okada et al. (14), who observed that ATP induced change in
the membrane potential of mouse L cells and human fibro-
blasts, a variety of adenosine- and ATP-induced responses in
fibroblasts were reported. These actions of adenosine and ATP,
which include regulation of cell growth, cytoskeletal contrac-
tion, Ca21 efflux, and LDH and nucleotide release (15–19),
were proposed to be mediated by A1, A2, P2X, P2Z (in current
terminology P2X7), and P2Y1 receptors (15–23). In one study
with human skin fibroblasts, actions of ATP on Ca21 mobiliza-
tion and phospholipase C activity were mimicked by UTP (24),
although no further characterization of the receptor(s) mediat-
ing UTP responses in fibroblasts was provided.
The effects of extracellular nucleotides have also been exten-
sively studied on airway epithelia, and attempts have been
made to link the cellular responses to specific nucleotide recep-
tors. Both ATP and UTP equipotently regulate epithelial elec-
trolyte and water transport (3, 25), trigger mucin secretion (26,
27), and increase ciliary beat frequency (28–30). ATP and UTP
equipotently stimulate inositol phosphate formation (29) and
Ca21i mobilization and exhibit cross-desensitization (3). These
data suggest that a common receptor for ATP and UTP is
expressed on the airway epithelia, which pharmacologically is
most likely to be the P2Y2-R. However, receptors that are
activated by UDP (31) and adenosine (32) may also be ex-
pressed on these cells and thus complicate this analysis.
In this study, we generated a mouse line carrying a mutant
P2Y2 allele. We used these mice to examine the relative role of
P2Y2-R in the nucleotide-promoted Ca
21 signaling in mouse
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lung fibroblasts and airway epithelial cells. The role of P2Y2-R
was tested by comparison of nucleotide-stimulated Ca21i re-
sponses in cells from P2Y2-R (2/2) mice with those from wild
type animals. In the accompanying paper (33), the role of
P2Y2-R in mediating Cl
2 secretory responses in freshly excised
tracheal, gallbladder, and jejunal tissues is described.
MATERIALS AND METHODS
Generation of P2Y2-R-deficient Mice—A targeting vector was de-
signed such that DNA corresponding to base pairs 552–1149 of the
published P2Y2-R cDNA was replaced with the neomycin gene upon
integration of the targeting plasmid into the genome by homologous
recombination. The targeting plasmid contains two regions of DNA with
homology to the endogenous locus. The targeting vector was con-
structed by cloning two genomic DNA fragments into the JNS2 vector:
a 2500-base pair fragment extending from an XhoI site in the 59 region
of the gene to a SmaI site located at base pair 552 of the published
cDNA and a fragment extending 6500 bases 39 from the EagI site at
base pair 1149 of the coding sequence. The targeting vector was elec-
troporated into E142aTG cells, and resulting neomycin- and gancyclo-
vir-resistant colonies were isolated. DNA from surviving colonies was
isolated, digested with BamHI, and analyzed by Southern blot analysis
using a probe located immediately upstream of the P2Y2-R genomic
fragments not included in the targeting vector. Chimeric mice were
generated with P2Y2-R-targeted E142aTG cell lines and were bred to
B6D2 mice. Offspring were identified by Southern blot analysis of tail
DNA, using probes described above.
Total cellular RNA was isolated from kidneys of P2Y2-R(1/1) and
P2Y2-R(2/2) mice with RNAzol B (TelTest, Inc., Friendswood, TX), as
per the manufacturer’s instructions. Twenty mg of RNA were electro-
phoresed in a 1.2% agarose formaldehyde gel, blotted to an Immo-
bilon-NC transfer membrane (Millipore Corp., Bedford, MA), and UV-
cross-linked. The membranes were hybridized with a 32P-labeled
P2Y2-R cDNA for 1 h at 68 °C using Quikhyb reagent (Stratagene, La
Jolla, CA), and blots were washed twice with 23 SSC, 0.1% SDS and
once with 0.23 SSC, 0.1%SDS at 42 °C for 15 min each. The P2Y2-R
cDNA corresponds to base pairs 267–1097.
For histological analysis, all animals were exsanguinated by severing
the aorta after receiving an intraperitoneal injection of a lethal dose of
chloral hydrate (1 ml of a 20 mg/ml solution). Organs were immersed in
10% phosphate-buffered neutral formalin (pH 7.0) for at least 24 h. The
organs then were embedded in paraffin, dehydrated, and sectioned for
histological analysis with hematoxylin and eosin.
Adult mice (wild type and P2Y2(2/2)) of both sexes were used in this
investigation. All animals were bred and raised at the University of
North Carolina at Chapel Hill. All mice were allowed food and water ad
libitum until euthanized.
Cell Culture—Wild type and P2Y2-R(2/2) mice were euthanized
with 100% CO2. Lung fibroblasts were isolated by mincing freshly
excised lung parenchyma into ;1-mm3 pieces and establishing explant
cultures on plastic tissue culture plates in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum. Outgrowth fibro-
blasts were harvested with 0.1% trypsin plus 1 mM EDTA in phosphate-
buffered saline 1–3 weeks after initial plating. The cells were seeded on
glass coverslips coated with 0.3 mg/ml Vitrogen (Collagen Biomaterials,
CA) and cultured for 36–48 h. Nearly confluent cultures were used for
study.
To isolate epithelial cells, the trachea and nasal turbinates were
removed from the animals and dissected free of blood vessels and
connective tissues. The airway epithelial cells were disaggregated from
the tissues by a 4-h treatment with 0.1% protease XIV (Sigma), epithe-
lial cells isolated by centrifugation, and cells were seeded at a 5 3 105
cells/cm2 density on Vitrogen-coated glass coverslips. The cells were
allowed to attach for 24 h in Ham’s F-12-based medium containing 10
mg/ml insulin, 5 mg/ml transferrin, 1 mM hydrocortisone, 30 nM triiodo-
thyronine, 25 ng/ml epidermal growth factor, 3.75 mg/ml endothelial cell
growth substance, 0.8 mM Ca21 (total), and an equal amount of 3T3
fibroblast-conditioned Dulbecco’s modified Eagle medium containing
2% fetal bovine serum, following which the cultures were gently washed
and maintained for an additional 24–36 h before study. Only well
attached cell clusters containing equal numbers of ciliated and noncili-
ated cells were used for Ca21i studies.
Ca21i Measurements—The cell cultures were washed with hormone-
free Ham’s F-12 medium and incubated with 3 mM Fura-2/AM for 30
min at 37 °C. After the loading period, the cells were washed twice with
Ringer solution (130 mM Na1, 128 mM Cl2, 5 mM K1, 1.3 mM Ca21, 1.3
mM Mg21, 5 mM glucose, and 10 mM Hepes, pH 7.4) and mounted in a
microscope chamber. The fluorescence (.450 nm) of 30–50 cells was
alternately acquired at 340- and 380-nm excitation by a RatioMaster
RM-D microscope fluorimetry system (Photon Technology Inc., Mon-
mouth Junction, NJ) at room temperature. A Zeiss Axiovert 35 micro-
scope and a Nikon UV-F 3 100 (1.3) glycerol immersion objective were
used. After each experiment, the cells were lysed with 40 mM digitonin,
and the background fluorescence was determined by quenching tech-
nique using 4 mM MnCl2.
Inositol Phosphate Studies—Inositol phosphate measurements were
performed as described previously (34). In brief, cells grown on Vitro-
gen-coated glass coverslips were labeled overnight with 5 mCi/ml myo-
[3H]inositol in inositol-free Dulbecco’s modified Eagle’s medium con-
taining 4.5 g/liter glucose. The cells were then preincubated with 10 mM
LiCl for 15 min and challenged with agonist for an additional 15 min.
The incubations were terminated by the addition of 5% ice-cold trichlo-
roacetic acid. The accumulated [3H]inositol phosphates were separated
on Dowex AG1-X8 anion exchange columns and quantified in a scintil-
lation counter (31).
Reagents—Hormones for cell culture were purchased from Collabo-
rative Research, Inc. (Bedford, MA) with the exception of triiodothyro-
nine, which was from Sigma; other cell culture materials were pur-
chased from Life Technologies, Inc. Molecular biology grade ATP and
UTP were purchased from Amersham Pharmacia Biotech (Uppsala,
Sweden). Hexokinase, UDP, ADP, and adenosine were from Roche
Molecular Biochemicals. 2-methylthio-ATP (2-MeSATP), 2-methylthio-
ADP (2-MeSADP), a,b-methylene ATP (a,b-meATP), and digitonin
were obtained from RBI (Natick, MA). Fura-2/AM, Fura-2 pentapotas-
sium salt, and Ca21 calibration buffers were purchased from Molecular
Probes, Inc. (Eugene, OR). myo-[3H]inositol (20 Ci/mmol) was from ARC
(St. Louis, MO). All other chemicals were purchased from Sigma. To
remove triphosphate contamination from diphosphate nucleotides, 1
mM stock solutions of UDP, ADP, and 2-MeSADP were pretreated with
10 units/ml hexokinase for 30 min at 37 °C in the presence of 5 mM
glucose (10).
Data Analysis—For Ca21i measurements, the background corrected
ratio values (340/380) were calibrated by using the formula originally
proposed by Grynkiewicz et al. (35). The optical parameters of the
system, Rmax, Rmin, and Kd values were determined by using 1 mM
Fura-2 free acid and a series of Ca21 buffers. Differences between the
peak and basal Ca21i concentration were plotted. The data are pre-
sented as mean 6 S.E. For comparisons, the mean values were analyzed
FIG. 1. Targeted disruption of the P2Y2-R gene. A, construction
of the P2Y2-R targeting vector. B, confirmation of targeting by Northern
blot analysis. RNA was generated from kidneys of a P2Y2-R(1/1) and a
P2Y2-R(2/2) mouse. P2Y2-R is present in the kidneys of the wild type
mouse but is absent in the kidneys of the P2Y2-R(2/2) mouse. B,
BamH1; E, EcoRI; S, SmaI; X, XbaI; N, NotI.
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by unpaired t tests. The significant differences (p , 0.05) are indicated
by asterisks.
RESULTS
Generation of P2Y2-R-deficient Mice—Mice deficient in
P2Y2–R were generated by targeted mutagenesis of the P2Y2-R
gene in mouse embryonic stem cells (Fig. 1A). RNA isolated
from kidneys of a P2Y2-R(1/1) and P2Y2-R(2/2) mouse con-
firmed the complete loss of P2Y2-R in the P2Y2 (2/2) mouse
(Fig. 1B). Mice homozygous for the mutant P2Y2-R allele were
obtained at the expected frequency, were fertile, and could not
be distinguished from wild type littermates. No differences
were seen on histological analysis of all organs analyzed, in-
cluding the kidney, heart, testes, pancreas, liver, trachea,
lungs, salivary glands, and gastrointestinal tract.
Effects of Nucleotides on Inositol Phosphate Accumulation
and Intracellular Ca21 Levels in Murine Lung Fibroblasts—
The effects of nucleotides were studied in cultured lung fibro-
blasts isolated from wild type and P2Y2-R(2/2) mice. Changes
in the intracellular Ca21 concentration ([Ca21]i) were moni-
tored by using Fura-2 fluorescent indicator, and nucleotide-
induced [3H]inositol phosphate formation was measured in
myo-[3H]inositol-labeled cells (Fig. 2). In wild type fibroblasts,
UTP and ATP promoted dose-dependent Ca21i (Fig. 2A) and
inositol phosphate responses (Fig. 2B). ADP induced only a
small Ca21i response at high concentrations. UDP had no sub-
stantial effect.
Both Ca21i and inositol phosphate responses to nucleotides
were abolished in P2Y2-R(2/2) fibroblasts (Fig. 2, C and D).
Similarly, ADP and UDP did not induce responses over back-
ground in these cells. These data indicate that the P2Y2 recep-
tor is the only nucleotide receptor functionally expressed in
murine lung fibroblasts.
Characterization of Nucleotide-induced Responses in Wild
Type Airway Epithelial Cells—Primary murine airway epithe-
lial cells have a limited growth capacity. Therefore, in experi-
ments with airway epithelia, we focused only on Ca21i meas-
urements and confined our pharmacologic characterizations to
two concentrations of nucleotide agonists. The two concentra-
tions (1 and 100 mM) of nucleotides studied were selected on the
basis of previous studies of human nasal cells, where 100 mM
ATP and UTP induced a maximal effect, and their EC50 values
were in the low micromolar concentration range (3).
ATP and UTP promoted substantial Ca21i responses at both
1 and 100 mM concentrations in tracheal cells from wild type
mice (Fig. 3A). ADP, 2-MeSATP, and 2-MeSADP were effective
only at the 100 mM concentration, while UDP had no measur-
able effect. A similar pattern was found in nasal cells (Fig. 3B),
with the exception that, in the latter, the maximal responses to
100 mM agonist concentrations were generally smaller, whereas
the 2-MeSATP and 2-MeSADP responses were relatively larger
at the 1 mM concentration.
To investigate possible cross-desensitization between ago-
nists in nucleotide-promoted Ca21i responses, isolated tracheal
and nasal cells were exposed first to successive additions of a
100 mM concentration of a given agonist until no further change
in Ca21i signal was observed. Subsequently, the cells were
exposed to 100 mM of a second agonist in the continued presence
of the first one.
The results obtained from wild type tracheal cells are shown
in Fig. 4. UTP pretreatment markedly, but not completely,
reduced the Ca21i response to ATP (Fig. 4A), whereas ATP
pretreatment completely abolished the UTP-induced Ca21i re-
sponse (Fig. 4B). Pretreatment with ADP, and 2-MeSATP had
no significant effect on ATP or UTP-induced Ca21i responses
(Fig. 4, A and B). The Ca21i signal elicited by 2-MeSATP was
entirely abolished by ATP pretreatment (Fig. 4C). UTP or
2-MeSADP pretreatment also reduced, although only partially,
FIG. 2. Concentration-effect curves for nucleotide-stimulated
Ca21 responses (DCa21i) and [
3H]inositol phosphate formation
in mouse lung fibroblasts. Cells isolated from wild type (A, B) and
P2Y2-R(2/2) mice (C, D) were exposed to the indicated concentration of
ATP (●), UTP (f), ADP (), or UDP (Œ). Changes in Ca21i were
measured immediately after the addition of agonist to Fura-2-loaded
cells (top panels). Values are mean 6 S.E. of changes from basal to peak
concentration (n 5 3–12/concentration). myo-[3H]Inositol-labeled cells
were preincubated with LiCl and subsequently challenged with
the indicated nucleotide for 15 min (B, D). Counts from accumulated
[3H]inositol phosphates over the background were plotted. Each data
point represents the mean 6 S.E. of three independent experiments
performed in triplicate.
FIG. 3. Nucleotide-induced Ca21 responses (DCa21i) in wild-
type murine tracheal (A) and nasal (B) epithelial cells. Changes
in [Ca21]i in response to 1 and 100 mM concentrations of the indicated
nucleotide were measured in Fura-2-loaded airway epithelial cells iso-
lated from wild type mice. Maximal changes in [Ca21]i (from basal to
peak) in response to the agonists were plotted (n 5 3–14).
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the 2-MeSATP-induced responses. These findings suggest the
functional expression of both a common receptor for ATP and
UTP and an additional adenine nucleotide receptor(s).
Fig. 4 also summarizes the desensitization experiments per-
formed with wild type nasal epithelial cells. A partial cross-
desensitization between ATP and UTP was observed in this cell
type (Fig. 4, D and E). Pretreatment with ADP did not signif-
icantly alter the response induced by ATP or UTP, whereas
2-MeSATP pretreatment significantly attenuated both ATP-
and UTP-stimulated signals. The Ca21i response to 2-MeSATP
was eliminated by ATP or 2-MeSADP pretreatment (Fig. 4F).
Taken together, these results are also consistent with the ex-
pression of a common receptor for ATP and UTP and, possibly,
an additional ADP receptor.
Nucleotide-induced Ca21 Responses in Airway Epithelial
Cells from P2Y2-R(2/2) Mice—A potential candidate for the
common ATP/UTP receptor in airway epithelial cells is the
P2Y2 receptor. To test the involvement of P2Y2 receptor in the
murine airway epithelium, Ca21i studies were performed on
tracheal and nasal cells isolated from P2Y2-R(2/2) mice. The
UTP-induced Ca21i responses were abolished in both tracheal
(Fig. 5A) and nasal cells (Fig. 5B). The magnitude of ATP-
stimulated Ca21i responses was substantially reduced in P2Y2-
R(2/2) tracheal and nasal epithelial cells, but residual Ca21i
responses were measurable. The reductions in the responses to
100 mM ATP in wild type and P2Y2-R(2/2) tracheal and nasal
cells (Figs. 3 and 5, respectively) were 74.5 and 44.0% (p ,
0.02), respectively.
ADP, 2-MeSATP, and 2-MeSADP elicited Ca21i responses in
both tracheal and nasal cells from P2Y2-R(2/2) mice, whereas
UDP had no substantial effect in either. A slight reduction in
responses induced by 100 mM ADP and 2-MeSATP was ob-
served in the P2Y2-R(2/2) tracheal cells, but Ca
21
i responses
induced by 100 mM 2-MeSADP in both P2Y2-R(2/2) tracheal
and nasal cells were not significantly different from that found
in wild type cells.
These results clearly demonstrate that the P2Y2 receptor is
the major but not the unique nucleotide receptor functionally
expressed in murine tracheal and nasal epithelial cells.
Identification of the Residual Nucleotide Receptor in P2Y2-
R(2/2) Airway Epithelial Cells—Next, we initiated a series of
experiments to identify the nucleotide receptor type(s) that
accounted for the residual Ca21i responses induced by adenine
nucleotides. To test for the involvement of adenosine receptors
in ATP-promoted responses, P2Y2-R(2/2) cells were exposed to
100 mM ATP in the presence or absence of 1 unit/ml adenosine
deaminase. In tracheal cells, ATP stimulated a 65.4 6 17 nM
(n 5 3) change in Ca21i in the presence of enzyme, which was
not significantly different from the values obtained in its ab-
sence, 92.4 6 40 nM (n 5 10). In nasal cells, the ATP-induced
Ca21 responses were 103.8 6 65 (n 5 4) and 108.9 6 29 nM (n 5
11) in the presence and absence of adenosine deaminase, re-
spectively. In addition, no Ca21i response was elicited by 100
mM adenosine in either tracheal or nasal epithelial cells (1.5 6
1.0 and 4.2 6 0.2 nM, respectively (n 5 3)).
Next, we tested for the possible involvement of P2X receptors
(36). To investigate this issue, 100 mM a,b-meATP was applied
to the P2Y2-R(2/2) tracheal and nasal cells. No Ca
21
i response
was elicited by this compound in either cell type (DCa21i in
nose, 5.2 6 3.9 nM, n 5 3; DCa21i in trachea, 4.8 6 1.0 nM, n 5
5). Further, ATP-induced Ca21i responses in Ca
21-free buffer
were not different from those found in the presence of 1.3 mM
Ca21 in either wild type (Fig. 6A) or P2Y2-R(2/2) (Fig. 6B)
FIG. 4. Desensitization of nucleotide-stimulated Ca21 re-
sponses in wild type tracheal and nasal epithelial cells. A, B, and
C, tracheal Ca21 responses induced by 100 mM ATP, UTP, or 2-MeSATP
were measured following no preaddition (None) or preaddition of a 100
mM concentration of the nucleotides indicated at the bottom of each
column. Responsiveness of the cells was tested by adding 200 mM
carbachol after each individual experiment. The values are mean 6 S.E.
(n 5 3–7). D, E, and F, desensitization studies with wild type nasal
epithelial cells were performed with the same protocol detailed above.
The values are mean 6 S.E. (n 5 3–6). The asterisks indicate significant
differences between responses with or without pretreatment (p , 0.05).
n.d., not determined)
FIG. 5. Effect of nucleotides on tracheal (A) and nasal (B) epi-
thelial cells isolated from P2Y2-R(2/2) mice. For details, see the
legend of Fig. 2.
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epithelial cells. These results strongly suggest that P2X recep-
tors do not mediate the residual ATP-induced responses.
Cross-desensitization experiments with P2Y2-R(2/2) tra-
cheal cells indicate that the Ca21i response to ATP was elimi-
nated when the cells were pretreated with ADP or 2-MeSATP
but not with UTP (Fig. 7A). Similarly, pretreatment with ATP
or 2-MeSADP entirely abolished the 2-MeSATP-induced re-
sponse in these cells (Fig. 7B). Studies with P2Y2-R(2/2) nasal
cells produced comparable results; pretreatment with ADP,
2-MeSATP, or 2-MeSADP abolished the ATP-induced Ca21i
signal (Fig. 7C). Similarly, the Ca21i response to 2-MeSATP
was eliminated when cells were pretreated with ATP, ADP, or
2-MeSADP (Fig. 7D). These results suggest one common recep-
tor for ATP, ADP, 2-MeSATP, and 2-MeSADP in the P2Y2-
R(2/2) tracheal and nasal epithelial cells. This pattern of
agonists resembles the nucleotide-agonist profile of P2Y1 re-
ceptor described in many species, including the murine P2Y1
receptor (37).
To directly investigate the involvement of the P2Y1 receptor
in P2Y2-R(2/2) airway epithelial Ca
21
i signaling, the effect of
A3P5P, a P2Y1 receptor-selective antagonist (38), on the 2-Me-
SADP-induced Ca21i responses was studied (Fig. 8). 2-Me-
SADP (1 mM) induced substantial Ca21i responses in both wild
type (Fig. 8A) and P2Y2-R(2/2) tracheal cells (Fig. 8B). The
mean values for 2-MeSADP-induced changes in Ca21i were
74.9 6 23.2 nM (n 5 7) and 50.4 6 17.4 nM (n 5 7) for wild type
and P2Y2-R(2/2) mice, respectively. A3P5P (100 mM) alone did
not stimulate Ca21 responses, but it completely blocked the
effect of 2-MeSADP (Fig. 8, right traces). The 2-MeSADP-in-
duced changes in Ca21i in the presence of A3P5P were signif-
icantly reduced compared with responses without A3P5P: 9.8 6
5.0 nM (n 5 3) and 8.9 6 3.7 nM (n 5 4) in wild type and
P2Y2-R(2/2) cells, respectively. Similar inhibitory effects of
A3P5P were observed in P2Y2-R(2/2) nasal epithelial cells; the
mean changes in Ca21i in response to 1 mM 2-MeSADP were
91.2 6 23.5 nM (n 5 3) and 6.5 6 2.5 nM (n 5 3) in the absence
and presence of A3P5P, respectively. In contrast, A3P5P did
not affect the UTP-stimulated Ca21i response in wild type cells
(Fig. 8A), consistent with the lack of effect of A3P5P on the
P2Y2 receptor. Moreover, the carbachol-induced response in
FIG. 6. Effect of extracellular Ca21 on the ATP-induced Ca21
response in tracheal and nasal epithelial cells. Cells isolated from
wild type (A) and P2Y2-R(2/2) (B) mice were challenged with 100 mM
ATP in the presence and absence of extracellular Ca21 (n 5 3–11).
FIG. 7. Desensitization studies in P2Y2-R(2/2) tracheal and
nasal epithelial cells. A, tracheal cell Ca21 responses induced by 100
mM ATP (A) or 2-MeSATP (B) following no preaddition (None), or pre-
addition of 100 mM of nucleotide indicated at the bottom of each column.
Similar protocols were used with nasal epithelial cells (C, D). The
experiments were carried out as described in the legend of Fig. 3. The
values are mean 6 S.E. (n 5 3–7). The asterisks indicate significant
differences between responses with or without pretreatment (p , 0.05).
n.d., not determined.
FIG. 8. Effect of A3P5P on the 2-MeSADP-induced Ca21 re-
sponse in mouse tracheal epithelial cells. Wild type (A) and
P2Y2(2/2) (B) mouse tracheal cells were exposed to 1 mM 2-MeSADP in
the presence and absence of 100 mM A3P5P. Responsiveness of the cells
was tested by adding 100 mM UTP in wild type or 1 mM carbachol in
P2Y2-R(2/2) cells at the completion of each experiment. The traces are
representative of seven independent experiments.
Purinergic Characterization of Mouse Pulmonary Cells26458
the P2Y2-R(2/2) cells also were not affected by A3P5P (Fig.
8B), further excluding nonspecific effects of A3P5P on Ca21i
signaling. Taken together, these data suggest that the residual
P2 receptor in the P2Y2-R(2/2) murine airway epithelia is the
P2Y1 receptor.
DISCUSSION
The murine P2Y2-R gene was disrupted by homologous re-
combination in embryonic stem lines and mice homozygous for
the disrupted P2Y2-R gene generated from these lines. These
P2Y2-R-deficient mice provide a unique tool for characteriza-
tion of extracellular nucleotide regulation of cell signaling.
We investigated three different cell types isolated from lungs
of wild type and P2Y2 receptor (-/-) mice: lung fibroblasts and
tracheal and nasal epithelial cells. Because of the absence of
specific and potent antagonists, binding assays have not been
useful in studies characterizing tissue-specific expression of
nucleotide receptors (39). Therefore, we have measured nucle-
otide-induced Ca21 responses and, when possible, inositol lipid
hydrolysis to characterize nucleotide receptor function in cells
from these wild type and P2Y2 receptor-deficient mice.
A good correlation between Ca21i responses and inositol
phosphate formation was observed in lung fibroblasts (Fig. 2, A
and B). The dose-effect relationships for nucleotide agonists
and Ca21i and inositol phosphate measurements were identi-
cal. The rank orders of agonist potencies (UTP $ ATP ..
ADP . UDP) were similar in both assays and were consistent
with the pharmacological profile of the P2Y2 receptor. How-
ever, the recently cloned rat P2Y4 receptor displays a similar
pattern of triphosphate nucleotide responses (40, 41), raising
the possibility that its mouse homologue may do so as well.
A definitive description of which nucleotide receptor sub-
type(s) accounted for the effect of UTP and ATP in the murine
lung fibroblast resulted from the experiments with cells iso-
lated from P2Y2-R(2/2) mice (Fig. 2, C and D). These data,
demonstrating that disruption of the gene encoding the P2Y2
receptor completely abolished nucleotide-induced inositol phos-
phate and Ca21 responses, establish that the P2Y2 is the only
P2 receptor functionally expressed in mouse lung fibroblasts.
Further studies will be required to extend this characterization
to nonlung fibroblasts and the potential influence of continuous
culture to assess the relevance of this conclusion to those in
previous reports.
Because of smaller numbers and limited growth capacity of
the epithelial cells, we focused on nucleotide-induced Ca21i
responses rather than on inositol lipid hydrolysis in this cell
type. Tracheal epithelial cells from wild type mice exhibited a
rank order of nucleotide-induced responses (Fig. 3A) similar to
that reported with the cloned human and mouse P2Y2 receptor
(7, 10). Desensitization studies carried out with wild type tra-
cheal cells provided further support for the hypothesis that a
common UTP/ATP receptor is expressed in these cells (Fig. 4).
Direct, unambiguous evidence for P2Y2 expression in the
murine trachea was provided by studies with P2Y2-R(2/2)
tracheal cells. The complete abolition of UTP-induced Ca21i
responses clearly demonstrated that P2Y2 receptor accounted
for the effect of UTP in wild type tracheal cells, and no other
UTP-activated receptor (i.e. P2Y4 receptor) was present (Fig.
5A). The absence of effect of UDP in the P2Y2-R(2/2) cells also
ruled out involvement of P2Y6 receptors. The major (75%)
reduction in ATP-stimulated Ca21 response clearly demon-
strated that P2Y2 receptor was the predominant but not unique
receptor for ATP in this cell type. The reduction in the magni-
tude of the response to 2-MeSATP suggests that this nonselec-
tive P2Y1/P2X receptor agonist also stimulates the P2Y2 recep-
tor at high concentrations. This observation is consistent with
the effect of 2-MeSATP reported with the cloned P2Y2 receptor
(10).
Mouse nasal epithelial cells exhibited a profile of nucleotide-
stimulated responses similar to that observed in tracheal cells
(Figs. 3 and 4). The ATP/UTP responses were generally larger
in wild type tracheal cells than in nasal cells, whereas the
magnitude of residual ATP-stimulated responses in P2Y2-
R(2/2) cells was similar in cells from each region (Fig. 5). This
observation suggests a higher level of expression of the P2Y2
receptor in tracheal cells than nasal cells.
A second objective of our study was to identify additional
nucleotide receptor(s) that might be expressed in mouse airway
epithelial cells. The absence of specific agonists and antago-
nists for most of the P2 receptors makes it difficult to classify
multiple receptors in a complex system. However, the P2Y2-
R(2/2) mouse model facilitated these studies.
Our results provide direct evidence for the functional expres-
sion of P2 receptor(s) other than P2Y2 that are activated by
adenine nucleotide agonists in murine tracheal and nasal epi-
thelial cells. The involvement of P1 adenosine receptors in the
ATP-induced Ca21 response was ruled out on the bases that
adenosine did not stimulate elevation in intracellular Ca21
levels and that adenosine deaminase pretreatment did not
affect the response to ATP in P2Y2-R(2/2) cells. a,b-meATP,
originally thought to be specific for all P2X receptors (4), is now
known to be active only at P2X1 and P2X3 receptors (36, 42, 43).
In mouse airway epithelial cells, a,b-meATP was inactive in
terms of Ca21 signaling (see “Results”) as well as Cl2 secretion
(33). We cannot entirely rule out the involvement of P2X re-
ceptors solely on the basis of the absence of a,b-meATP-induced
responses. However, the experiments carried out in Ca21-free
buffer (Fig. 6) clearly demonstrated that ATP-stimulated Ca21
responses primarily reflected release from internal stores and
not direct opening of plasma membrane P2X (Ca21) channels.
These findings strongly suggest that the P2X receptors are not
functionally expressed in these cells.
The residual effects of ATP, ADP, 2-MeSATP, and 2-Me-
SADP found in P2Y2-R(2/2) cells (Fig. 5), coupled with the
desensitization studies (Fig. 7), are more consistent with the
expression of P2Y1 receptor (44–46) than a P2Y11 receptor,
because the latter is not activated by the diphosphate ana-
logues (13). The substantial Ca21i responses elicited by ADP
and 2-MeSADP in the P2Y2-R(2/2) cells (Fig. 5), coupled with
the antagonistic effect of A3P5P on the Ca21i response to 2-Me-
SADP-induced responses (Fig. 8), strongly supports the hy-
pothesis that the residual nucleotide receptor in the P2Y2-
R(2/2) airway cells is in fact the P2Y1 receptor.
The results of Ca21i measurements with tracheal epithelial
cells can be compared with the data obtained from the tracheal
Cl2 secretory studies in the accompanying paper (33). Our
studies were carried out on isolated tracheal cells grown on
glass coverslips, providing access of added agonists to apical
and basolateral membrane surfaces. In contrast, the Cl2 meas-
urements were performed with freshly excised tracheas with
additions only to the apical surface. Despite these differences,
the pharmacological profiles determined by theses two methods
were generally similar in tracheal specimens and revealed that
the P2Y2 receptor was the dominant receptor mediating both
Ca21i and Cl
2 secretory responses in wild type mice. A slight
difference was that in P2Y2-R(2/2) tracheal epithelia UDP had
a minor but potent effect on Cl2 secretion (33), whereas negli-
gible UDP responses were observed in the Ca21i studies (Fig.
5). The simplest explanation for this discrepancy is that the
UDP-activated receptor, probably P2Y6, was down-regulated
during culture on glass coverslips.
In summary, murine lung fibroblasts as well as tracheal and
nasal epithelial cells from wild type mice exhibit P2Y2-like
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pharmacologic responses to extracellular nucleotide additions.
Comparative studies of cells from P2Y2-R(1/1) and P2Y2-
R(2/2) mice provided direct evidence for P2Y2 receptor func-
tion in all three cell types. The P2Y2 receptor appears likely to
be the only P2 receptor in mouse lung fibroblasts and is the
predominant P2 receptor in airway epithelial cells. In addition,
the P2Y2-R(2/2) mouse model made it possible to functionally
characterize and identify another P2 receptor in airway epithe-
lia, which was masked by the activity of the dominant P2Y2
receptor. The residual nucleotide receptor in mouse tracheal
and nasal epithelial cells is most likely the P2Y1 receptor.
Although conclusions regarding humans cannot be directly
drawn from studies performed in mice, the P2Y2-R(2/2) mouse
model system provides a unique tool for tissue-specific nucleo-
tide receptor function.
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